drugset / Trial / NCT01455675
Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to prolong the time to reinfection with Pseudomonas aeruginosa after successfully treated acute or intermittent infection.
Timeline
- Start
- 2011-10
- Primary completion
- 2017-06-27
- Completion
- 2017-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IgY | Protein / enzyme biologic | 50 mg | Other |